Wuxi Taclink Eyes Singapore Listing, A First for Dual-Listed Chinese Firm
10h ago|4 min readStandard
Fazen Markets Editorial Desk
Collective editorial team · methodology
wuxi-taclinksingapore-ipo
Fazen Markets Editorial Desk
Collective editorial team · methodology
Trades XAUUSD 24/5 on autopilot. Verified Myfxbook performance. Free forever.
Risk warning: CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. The majority of retail investor accounts lose money when trading CFDs. Vortex HFT is informational software — not investment advice. Past performance does not guarantee future results.
Wuxi Taclink Optoelectronics Technology Co. is considering a listing on the Singapore Exchange, according to a report published May 29, 2026. The move would mark the first instance of a company already trading on a mainland Chinese exchange pursuing a secondary listing in Singapore. The firm currently trades on the Shenzhen Stock Exchange under ticker 002137. Its shares closed at CNY 44.20 on May 28, giving it a market capitalization of approximately CNY 32.8 billion ($4.5 billion).
Chinese companies have primarily pursued secondary listings in Hong Kong, not Singapore. The last significant Chinese tech listing in Singapore was NIO's secondary offering in 2022, which raised $1.5 billion. That deal was structured differently as NIO's primary listing was already in New York, not mainland China.
The current macro backdrop features tightening capital controls in China and geopolitical friction with the US. The 10-year US Treasury yield sits at 4.21%, while the Shanghai Composite Index trades near 3,150.
A key catalyst is Singapore's growing role as a neutral financial hub for pan-Asian capital. Regulatory approval from Chinese authorities would be a prerequisite for this cross-border listing. This creates a potential pathway for other Chinese firms to access Southeast Asian capital without routing through Hong Kong or the US.
The Singapore Exchange has actively courted high-tech Chinese firms since 2023. Its new listing framework offers faster processing for firms in sectors like optoelectronics and advanced manufacturing.
Wuxi Taclink's financial metrics provide context for the listing. The company reported revenue of CNY 8.2 billion ($1.13 billion) for the 2025 fiscal year. Its net profit margin was 14.7%, up from 12.1% in 2024.
| Metric | Wuxi Taclink | Sector Average (Shenzhen Optoelectronics) |
|---|---|---|
| P/E Ratio | 28.4x | 31.1x |
| Debt-to-Equity | 35% | 48% |
| ROE | 16.2% | 12.8% |
The company's stock price has gained 22% year-to-date, outperforming the CSI 300 Index's 3% gain. Its daily trading volume on the Shenzhen Exchange averages 12.5 million shares. The Singapore Exchange's total market capitalization is SGD 750 billion ($555 billion). Its electronics sector trades at an average P/E of 25x.
Secondary listings typically capture 15-25% of a company's total trading volume in the new market. A successful listing could add SGD 1.1-1.8 billion ($800 million - $1.3 billion) to SGX's electronics sector market cap.
The primary beneficiary is the Singapore Exchange (SGX). Its stock could see a re-rating if this listing triggers a pipeline of similar Chinese deals. The SGX/S&P Singapore Index has underperformed Hong Kong's Hang Seng Index by 18 percentage points over five years. A successful landmark listing could narrow that gap.
Chinese brokerage firms with strong Singapore desks, like CITIC Securities and China International Capital Corp, stand to gain underwriting fees. Southeast Asian asset managers like Temasek and GIC gain direct access to a new pool of Chinese industrial technology stocks.
The main risk is regulatory rejection from Chinese authorities. Beijing maintains strict controls on capital outflows. A green light for Wuxi Taclink would signal a calibrated easing, not a broad policy shift. The counter-argument is that Singapore's market lacks the depth of Hong Kong, potentially limiting valuation upside.
Positioning data shows hedge funds have been increasing exposure to Singapore-listed Chinese ADRs in recent months. Flow tracking indicates institutional interest in Southeast Asian exchanges as diversification plays away from US-China tensions.
The next catalyst is an official filing with the Singapore Exchange, expected by Q3 2026. Wuxi Taclink's Q2 2026 earnings report, due August 15, will provide an updated financial snapshot for the prospective listing prospectus.
Key levels to monitor include Wuxi Taclink's Shenzhen share price support at CNY 40.00. A break above CNY 48.50 would suggest the market is pricing in a successful listing premium. For the Singapore Exchange, watch the SGD 9.50 resistance level on its stock.
Chinese regulatory approval is the most significant variable. Watch for statements from the China Securities Regulatory Commission regarding cross-border listings in the coming weeks. The size of the Singapore offering will signal confidence. An offering above $500 million would be viewed as ambitious.
Existing shareholders on the Shenzhen exchange do not automatically receive shares in Singapore. The Singapore listing involves creating new shares sold to investors there. This can dilute existing ownership by 5-10% unless the company buys back shares concurrently. It provides a new currency for acquisitions and a secondary market for stock-based compensation, potentially improving talent retention.
Singapore's average daily turnover is approximately SGD 1.2 billion, significantly lower than Hong Kong's HKD 100 billion. For a single stock like Wuxi Taclink, liquidity would initially be thinner, which can increase volatility. However, Singapore attracts a different investor base focused on long-term, stable dividends and family offices, which may suit a industrial technology firm's profile.
The track record is mixed. Chinese firms with primary listings in the US and secondary listings in Hong Kong, like Alibaba and JD.com, often see their Hong Kong shares trade at a slight discount to their US ADRs, typically 2-4%. The arbitrage is limited by capital controls. A China-Singapore structure is untested, making Wuxi Taclink a critical precedent for future capital flow patterns.
Wuxi Taclink's potential Singapore listing tests a new channel for Chinese capital access, with success likely triggering imitators.
Disclaimer: This article is for informational purposes only and does not constitute investment advice. CFD trading carries high risk of capital loss.
Vortex HFT is our free MT4/MT5 Expert Advisor. Verified Myfxbook performance. No subscription. No fees. Trades 24/5.
Trade 800+ global stocks & ETFs
Start TradingSponsored
Open a demo account in 30 seconds. No deposit required.
CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money.